Bovisel SRL
The score of Bovisel shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +27 % Total assets -15 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Bovisel's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 29 Jan 2026
- Year ended 30 Jun 2024filed on 30 Jan 2025
- Year ended 30 Jun 2023filed on 30 Jan 2024
- Year ended 30 Jun 2022filed on 30 Jan 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
Bovisel's financial analysis
- Solvency85.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bovisel
Bovisel's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0826.254.314
- VAT number
- BE0826254314
- Peppol
- Registered · 0208:0826254314 · as of 27 Oct 2026
- Legal form
- SRL
- Incorporated
- 27 May 2010
- Registered office
- 8700 Tielt
- Latest accounts
- 2025 · filed on 29 Jan 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bovisel (SRL) has been based in Tielt since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 2,612 € and equity of 62,755 €; its revenue is not published. Its solvency stands at 85.5%, above the median of its sector (44.2%).
Companies similar to Bovisel
Companies in the same business, of comparable size and area, outside its group.
- Hubert Services Management Retail sale of pharmaceutical products Estinnes · balance sheet 65,144 €
- Quality Pharmaceutical Service Retail sale of pharmaceutical products La Bruyère · balance sheet 110,124 €
- Dynaderm Retail sale of pharmaceutical products Wavre · balance sheet 47,613 €
- Alchemiste Retail sale of pharmaceutical products Aalter · balance sheet 73,555 €
- Mieke DE Geeter Retail sale of pharmaceutical products Kortrijk · balance sheet 58,191 €
- Ahonzo Corporate Retail sale of pharmaceutical products Etterbeek · balance sheet 49,700 €
- Dynamo Medical Other non-specialised retail sale Kortrijk · balance sheet 25,094 €
- Sulayman Retail sale of pharmaceutical products Enghien · balance sheet 59,800 €
Frequently asked questions about Bovisel
What is the revenue of Bovisel?
Bovisel files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bovisel?
In Belgium, the VAT number is the company number prefixed with BE: BE0826254314 for Bovisel, if the company is VAT-registered. Its company number (CBE) is 0826.254.314.
Where is the registered office of Bovisel?
According to the CBE register, the registered office of Bovisel is in 8700 Tielt.
What is the equity of Bovisel?
At the close of the 2025 financial year, the equity of Bovisel amounts to 62,755 €, a solvency of 85.5% of total assets.
Who manages Bovisel?
The register lists 4 active mandates at Bovisel. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bovisel
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →